The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.

Jointly released last month in Rotterdam by the American Heart Association and American Academy of Pediatrics, these ...

Migraines affect many people globally. Scientists are exploring how nutrient deficiencies, like low Vitamin D, Magnesium, ...

The broadened approvals include pediatric formulations for rare tumor therapy and wider applications for blood cancers, ...

Teenagers worldwide are increasingly prescribed antidepressants. While these drugs help with depression and anxiety, concerns ...

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio ...

The EMA initially rejected Rezurock due to uncertainty over its clinical benefit, noting that the pivotal study had no comparator arm and permitted concomitant therapies.

Minimally invasive robot-assisted pars fracture surgery enabled most adolescent patients to return to sports in as little as six weeks, researchers with New York City-based Hospital for Special ...

Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

The Access to Basic Medical Care Foundation has emphasised the need for adolescent girls to receive the Human Papillomavirus ...

When I was 16 years old, I was targeted by a grown man. I was a junior in high school, and he was in his mid-20s. We met ...